Recce Pharmaceuticals
Recce Pharmaceuticals Ltd is an Australian pharmaceutical company focused on developing a new class of synthetic anti-infectives to combat antibiotic-resistant superbugs. Their lead candidate, RECCE® 327, has received Qualified Infectious Disease Product (QIDP) designation from the FDA, offering potential market exclusivity. The company aims to provide effective treatments against a broad range of bacteria and viral indications.
Short position
Recce Pharmaceuticals (ASX:RCE) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 4,267 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.37% in August 2021. RCE is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Recce Pharmaceuticals (RCE) short interest history
RCE Short Interest History
- 30-day change
- -0.00pp
- 90-day change
- +0.00pp
- 1-year change
- -0.08pp
- All-time high
- 0.37% (August 2021)
- All-time low
- 0.00% (May 2023)
Is RCE heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #651 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has RCE's short interest changed recently?
Over the past 30 days Recce Pharmaceuticals's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest RCE's short interest has been?
Since 2020, Recce Pharmaceuticals's short interest peaked at 0.37% in August 2021 and bottomed at 0.00% in May 2023.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2020. See our methodology.